DNA Methylation as a Biomarker for Preeclampsia

Biological Research for Nursing

Volumn 16, Issue 4, 2014, Pages 409-420

  Anderson, Cindy M ^a   Ralph, Jody L ^b   Wright, Michelle L ^b   Linggi, Bryan ^c   Ohm, Joyce E ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

^c U S DEPARTMENT OF ENERGY   (United States)

^d UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

biomarker; developmental origins of disease; epigenetics; pregnancy

Indexed keywords

BIOLOGICAL MARKER;

ADULT; BLOOD; CPG ISLAND; DNA METHYLATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; PREECLAMPSIA; PREGNANCY; PROSPECTIVE STUDY; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84907196756     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800413508645     Document Type: Article

References (74)

1. Abumaree M. H.,Chamley L. W.,Badri M.,El-Muzaini M. F.Trophoblast debris modulates the expression of immune proteins in macrophages: A key to maternal tolerance of the fetal allograft?.Journal of Reproductive Immunology. 2012;94:131-141
2. Anderson C. M.Preeclampsia: Exposing future cardiovascular risk in mothers and their children.Journal of Obstetric, Gynecologic, and Neonatal Nursing. 2007;36:3-8
3. Anderson C. M.,Lopez F.,Zhang H. Y.,Pavlish K.,Benoit J. N.Characterization of changes in leptin and leptin receptors in a rat model of preeclampsia.American Journal of Obstetrics and Gynecology. 2005a;193:267-272
4. Anderson C. M.,Lopez F.,Zhang H. Y.,Pavlish K.,Benoit J. N.Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant Sprague-Dawley rat.Biology of Reproduction. 2005b;72:762-766
5. Anderson C. M.,Lopez F.,Zhang H. Y.,Shirasawa Y.,Pavlish K.,Benoit J. N.Mesenteric vascular responsiveness in a rat model of pregnancy-induced hypertension.Experimental Biology and Medicine. 2006;231:13398-13402
6. Anderson C. M.,Lopez F.,Zimmer A.,Benoit J. N.Placental insufficiency leads to developmental hypertension and mesenteric artery dysfunction in two generations of Sprague-Dawley rat offspring.Biology of Reproduction. 2006;74:538-544
7. Arngrimsson R.Epigenetics of hypertension in pregnancy.Nature. Genetics. 2005;37:460-461
8. Barton J. R.,Sibai B. M.Prediction and prevention of recurrent preeclampsia.Obstetrics and Gynecology. 2008;112:359-372
9. Berends A. L.,de Groot C. J.,Sijbrands E. J.,Sie M. P.,Benneheij S. H.,Pal R.Steegers E. A.Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease.Hypertension. 2008;51:1034-1041
10. Bibikova M.,Barnes B.,Tsan C.,Ho V.,Klotzle B.,Le J. M.Shen R.High density DNA methylation array with single CpG site resolution.Genomics. 2011;98:288-295
11. Blumenstein M.,McMaster M. T.,Black M. A.,Wu S.,Prakash R.,Cooney J.North R. A.A proteomic approach identifies early pregnancy biomarkers for preeclampsia: Novel linkages between a predisposition to preeclampsia and cardiovascular disease.Proteomics. 2009;9:2929-2945
12. Carty D. M.,Delles C.,Dominiczak A. F.Preeclampsia and future maternal health.Journal of Hypertension. 2010;28:1349-1355
13. Chappell S.,Morgan L.Searching for genetic clues to the causes of pre-eclampsia.Clinical Science. 2006;110:443-458
14. Conde-Agudelo A.,Villar J.,Lindheimer M.World health organization systematic review of screening tests for preeclampsia.Obstetrics and Gynecology. 2004;104:1367-1391
15. Dedeurwaerder S.,Defrance M.,Calonne E.,Denis H.,Sotiriou C.,Fuks F.Evaluation of the infinium methylation 450K technology.Epigenomics. 2011;3:771-784
16. Doi A.,Park I. H.,Wen B.,Murakami P.,Aryee M. J.,Irizarry R.Feinberg A. P.Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts.Nature Genetics. 2009;41:1350-1353
17. Donkena K. V.,Young C. Y.,Tindall D. J.Oxidative stress and DNA methylation in prostate cancer.Obstetrics and Gynecology International. 2010;2010 (302051):
18. Esplin M. S.,Fausett M. B.,Fraser A.,Kerber R.,Mineau G.,Carrillo J.,Varner M. W.Paternal and maternal components of the predisposition to preeclampsia.New England Journal of Medicine. 2001;344:867-872
19. Fabry I. G.,Richart T.,Chengz X.,Van Bortel L. M.,Staessen J. A.Diagnosis and treatment of hypertensive disorders during pregnancy.Acta Clinica Belgica. 2010;65:229-236
20. Geelhoed J. J.,Fraser A.,Tilling K.,Benfield L.,Davey Smith G.,Sattar N.Lawlor D. A.Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: The Avon Longitudinal Study of Parents and Children.Circulation. 2010;122:1192-1199
21. Ghulmiyyah L.,Sibai B.Maternal mortality from preeclampsia/eclampsia.Seminars in Perinatology. 2012;36:56-59
22. Gruslin A.,Lemyre B.Pre-eclampsia: Fetal assessment and neonatal outcomes.Best Practice & Research: Clinical Obstetrics & Gynaecology. 2011;25:491-507
23. Hadker N.,Garg S.,Costanzo C.,Miller J. D.,Foster T.,van der Helm W.,Creeden J.Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: A decision-analytic modeling analysis from a UK healthcare payer perspective.Journal of Medical Economics. 2010;13:728-737
24. Harskamp R. E.,Zeeman G. G.Preeclampsia: At risk for remote cardiovascular disease.American Journal of the Medical Sciences. 2007;334:291-295
25. Herceg Z.Epigenetics and cancer: Towards an evaluation of the impact of environmental and dietary factors.Mutagenesis. 2007;22:91-103
26. Hogg K.,Blair J. D.,von Dadelszen P.,Robinson W. P.Hypomethylation of the LEP gene in placenta and elevated maternal leptin concentration in early onset pre-eclampsia.Molecular and Cellular Endocrinology. 2013;367:64-73
27. Hutcheon J.,Lisonkova S.,Joseph K. S.Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy.Best Practice & Research: Clinical Obstetrics & Gynaecology. 2011;25:391-403
28. Irizarry R. A.,Wu H.,Feinberg A. P.A species-generalized probabilistic model-based definition of CpG islands.Mammalian Genome. 2009;20:674-680
29. Jia R. Z.,Zhang X.,Hu P.,Liu X. M.,Hua X. D.,Wang X.,Ding H. J.Screening for differential methylation status in human placenta in preeclampsia using a CpG island plus promoter microarray.International Journal of Molecular Medicine. 2012;30:133-141
30. Jirtle R. L.,Skinner M. K.Environmental epigenomics and disease susceptibility.Nature Reviews. Genetics. 2007;8:253-262
31. Jones P. A.,Baylin S. B.The epigenomics of cancer.Cell. 2007;128:683-692
32. Klose R. J.,Bird A. P.Genomic DNA methylation: The mark and its mediators.Trends in Biochemical Sciences. 2006;31:89-97
33. Kucukgoz Gulec U.,Tuncay Ozgunen F.,Buyukkurt S.,Baris Guzel A.,Ferhat Urunsak I.,Cansun Demir S.,Cuneyt Evruke I.Comparison of clinical and laboratory findings in early- and late-onset preeclampsia.Journal of Maternal-Fetal & Neonatal Medicine. 2013;26:1228-1233
34. Kulkarni A.,Chavan-Gautam P.,Mehendale S.,Yadav H.,Joshi S.Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia.DNA and Cell Biology. 2011;30:79-84
35. Lahiri D. K.,Maloney B.,Zawia N. H.The LEARn model: An epigenetic explanation for idiopathic neurobiological diseases.Molecular Psychiatry. 2009;14:992-1003
36. Lampinen K. H.,Ronnback M.,Kaaja R. J.,Groop P. H.Impaired vascular dilatation in women with a history of pre-eclampsia.Journal of Hypertension. 2006;24:751-756
37. Lillycrop K. A.,Phillips E. S.,Jackson A. A.,Hanson M. A.,Burdge G. C.Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring.Journal of Nutrition. 2005;135:1382-1386
38. Liu A. X.,Jin F.,Zhang W. W.,Zhou T. H.,Zhou C. Y.,Yao W. M.Huang H. F.Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss.Biology of Reproduction. 2006;75:414-420
39. Liu B.,Xu Y.,Voss C.,Qiu F. H.,Zhao M. Z.,Liu Y. D.Wang Z. L.Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathways.PloS One. 2012;7:e44701
40. Lo J. O.,Mission J. F.,Caughey A. B.Hypertensive disease of pregnancy and maternal mortality.Current Opinion in Obstetrics & Gynecology. 2013;25:124-132
41. Lofton Day C.,Model F.,Devos T.,Tetzner R.,Distler J.,Schuster M.Sledziewski A.DNA methylation biomarkers for blood-based colorectal cancer screening.Clinical Chemistry. 2008;54:414-423
42. Loke Y.,Novakovic B.,Ollikainen M.,Wallace E.,Umstad M.,Permezel M.Craig J.The peri/postnatal epigenetic twins study (PETS).Twin Research and Human Genetics. 2013;16:13-20
43. Mangos G. J.Cardiovascular disease following pre-eclampsia: Understanding the mechanisms.Journal of Hypertension. 2006;24:639-641
44. Marin R.,Gorostidi M.,Portal C. G.,Sanchez M.,Sanchez E.,Alvarez J.Long-term prognosis of hypertension in pregnancy.Hypertension in Pregnancy. 2000;19:199-209
45. Martin A. C.,Brown M. A.Could uric acid have a pathogenic role in pre-eclampsia?.Nature Reviews. Nephrology. 2010;6:744-748
46. Martin J. A.,Hamilton B. E.,Ventura S. J.,Osterman M. J.,Kirmeyer S.,Mathews T. J.,Wilson E. C.Births: Final data for 2009.National vital statistics reports: From the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 2011;60:1-70
47. Moldenhauer L. M.,Keenihan S. N.,Hayball J. D.,Robertson S. A.GM-CSF is an essential regulator of T cell activation competence in uterine dendritic cells during early pregnancy in mice.Journal of Immunology. 2010;185:7085-7096
48. Müller H. M.,Ivarsson L.,Schrocksnadel H.,Fiegl H.,Widschwendter A.,Goebel G.Widschwendter M.DNA methylation changes in sera of women in early pregnancy are similar to those in advanced breast cancer patients.Clinical Chemistry. 2004;50:1065-1068
49. Ohm J. E.,Mali P.,Van Neste L.,Berman D. M.,Liang L.,Pandiyan K.Baylin S. B.Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.Cancer Research. 2010;70:7662-7673
50. Plasencia W.,Barber M. A.,Alvarez E. E.,Segura J.,Valle L.,Garcia-Hernandez J. A.Comparative study of transabdominal and transvaginal uterine artery doppler pulsatility indices at 11–13 + 6 weeks.Hypertension in Pregnancy. 2011;30:414-420
51. Qureshi I. A.,Mehler M. F.Emerging role of epigenetics in stroke: Part 1: DNA methylation and chromatin modifications.Archives of Neurology. 2010;67:1316-1322
52. Ray J. G.,Vermeulen M. J.,Schull M. J.,Redelmeier D. A.Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study.Lancet. 2005;366:1797-1803
53. Ren J.,Singh B. N.,Huang Q.,Li Z.,Gao Y.,Mishra P.Jiang S. W.DNA hypermethylation as a chemotherapy target.Cellular Signalling. 2011;23:1082-1093
54. Roberts J. M.,Hubel C. A.Pregnancy: A screening test for later life cardiovascular disease.Women's Health Issues. 2010;20:304-307
55. Roberts J. M.,Pearson G.,Cutler J.,Lindheimer M.Summary of the NHLBI working group on research on hypertension during pregnancy.Hypertension. 2003;41:437-445
56. Sandoval J.,Heyn H.,Moran S.,Serra-Musach J.,Pujana M. A.,Bibikova M.,Esteller M.Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome.Epigenetics. 2011;6:692-702
57. Schulz L. C.,Widmaier E. P.,Qiu J.,Roberts R. M.Effect of leptin on mouse trophoblast giant cells.Biology of Reproduction. 2009;80:415-424
58. Skjaerven R.,Vatten L. J.,Wilcox A. J.,Ronning T.,Irgens L. M.,Lie R. T.Recurrence of pre-eclampsia across generations: Exploring fetal and maternal genetic components in a population-based cohort.British Medical Journal. 2005;331:877
59. Smith G. C.,Pell J. P.,Walsh D.Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129,290 births.Lancet. 2001;357:2002-2006
60. Staff A. C.,Dechend R.,Pijnenborg R.Learning from the placenta: Acute atherosis and vascular remodeling in preeclampsia—novel aspects for atherosclerosis and future cardiovascular health.Hypertension. 2010;56:1026-1034
61. Stampalija T.,Gyte G. M.,Alfirevic Z.Utero-placental Doppler ultrasound for improving pregnancy outcome.Cochrane Database of Systematic Reviews (Online). 2010;9:CD008363
62. Tian X.,Pascal G.,Fouchecourt S.,Pontarotti P.,Monget P.Gene birth, death, and divergence: The different scenarios of reproduction-related gene evolution.Biology of Reproduction. 2009;80:616-621
63. Tunc O.,Tremellen K.Oxidative DNA damage impairs global sperm DNA methylation in infertile men.Journal of Assisted Reproduction and Genetics. 2009;26:537-544
64. Walker M. G.,Hindmarsh P. C.,Geary M.,Kingdom J. C.Sonographic maturation of the placenta at 30 to 34 weeks is not associated with second trimester markers of placental insufficiency in low-risk pregnancies.Journal of Obstetrics and Gynaecology Canada. 2010;32:1134-1139
65. Wang X.,Prins B. P.,Sober S.,Laan M.,Snieder H.Beyond genome-wide association studies: New strategies for identifying genetic determinants of hypertension.Current Hypertension Reports. 2011;13:442-451
66. Weaver I. C.,Diorio J.,Seckl J. R.,Szyf M.,Meaney M. J.Early environmental regulation of hippocampal glucocorticoid receptor gene expression: Characterization of intracellular mediators and potential genomic target sites.Annals of the New York Academy of Sciences. 2004;1024:182-212
67. Weber B.,Stresemann C.,Brueckner B.,Lyko F.Methylation of human microRNA genes in normal and neoplastic cells.Cell Cycle. 2007;6:1001-1005
68. Wessely F.,Emes R. D.Identification of DNA methylation biomarkers from Infinium arrays.Frontiers in Genetics. 2012;3:161
69. Williams P.,Broughton Pipkin F.The genetics of pre-eclampsia and other hypertensive disorders of pregnancy.Best Practice & Research: Clinical Obstetrics & Gynaecology. 2011;25:405-417
70. Wilson B. J.,Watson M. S.,Prescott G. J.,Sunderland S.,Campbell D. M.,Hannaford P.,Smith W. C.Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: Results from cohort study.British Medicine Journal. 2003;326:845
71. Wortelboer E. J.,Koster M. P.,Cuckle H. S.,Stoutenbeek P. H.,Schielen P. C.,Visser G. H.First-trimester placental protein 13 and placental growth factor: Markers for identification of women destined to develop early-onset pre-eclampsia.BJOG. 2010;117:1384-1389
72. Xiao Q.,Ye S.The genetics of epigenetics: Is there a link with cardiovascular disease.Heart. 2011;97:96-97
73. Yuen R. K.,Penaherrera M. S.,von Dadelszen P.,McFadden D. E.,Robinson W. P.DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia.European Journal of Human Genetics. 2010;18:1006-1012
74. Zawia N. H.,Lahiri D. K.,Cardozo-Pelaez F.Epigenetics, oxidative stress, and Alzheimer disease.Free Radical Biology & Medicine. 2009;46:1241-1249